Activation of signal transduction kinases by tamoxifen

Pharmaceutical Research

Volumn 14, Issue 2, 1997, Pages 186-189

  Duh, Jauh Lin ^a   Yu, Rong ^a   Jiao, Jie Jun ^a   Matwyshyn, George A ^a   Li, Wei ^b   Tan, Tse Hua ^c   Tony Kong, A N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

AP 1; ARE; ERK; JNK; MAP kinases; MAPK; NF B; Sinal transduction; Tamoxifen

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE; TAMOXIFEN;

ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, HORMONAL; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HELA CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; PRECIPITIN TESTS; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TAMOXIFEN;

EID: 0008413572     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012048626963     Document Type: Article

References (29)

1. J. R. Harris, M. E. Lippman, U. Veronesi, and W. Willett. N. Engl. J. Med. 327:473-480 (1992).
2. V. C. Jordan. Breast Cancer Res. Treatment 11:197-209 (1988).
3. M. C. Sunderland and C. K. Osborne. J. Clin. Oncol. 9:1283-1297 (1991).
4. E. F. Nuwaysir, Y. P. Dragan, C. R. Jefcoate, V. C. Jordan, and H. C. Pitot. Cancer Res. 55:1780-1786 (1995).
5. E. T. Hellriegel, G. A. Matwyshyn, P. Fei, K. H. Dragnev, R. W. Nims, R. A. Lubet, and A.-N. T. Kong. Biochem. Pharmacol. 52:1561-1568 (1996).
6. P. Fei, G. A. Matwyshyn, T. H. Rushmore, and A.-N. T. Kong. Pharm. Res. 13:1043-1048 (1996).
7. E. Pennisi. Science 273:1171 (1996).
8. V. C. Jordan and C. S. Murphy. Endocr. Rev. 11:578-610 (1990).
9. P. Webb, G. N. Lopez, R. M. Uht, and P. J. Kushner. Mol. Endocrinol. 9:443-456 (1995).
10. U. Gundimeda, Z. H. Chen, and R. Gopalakrishna. J. Biol. Chem. 271:13504-13514, 1996.
11. N. N. Yang, M. Venugopalan, S. Hardikar, and A. Glasebrook. Science 273:1222-1225 (1996).
12. M. H. Cobb and E. J. Goddsmith. J. Biol. Chem. 270:14843-14846 (1995).
13. R. Marais, J. Wynne, and R. Treisman. Cell 73:381-393 (1993).
14. J. M. Kyriakis, P. Banerjee, E. Nikolakaki, T. Dai, E. Rubie, M. Ahmad, J. Avach, and J. R. Woodgett. Nature 369:156-160 (1994).
15. B. Su, E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and Y. Ben-Neriah. Cell 77:727-736 (1994).
16. E. Cano, C. A. Hazzalin, and L. C. Mahadevan. Mol. Cell. Biol. 14:7352-7362 (1994).
17. V. Adler, A. Schaffer, J. Kim, L. Dolan, and Z. Ronai. J. Biol. Chem. 270:26071-26077 (1995).
18. B. Derijard, M. Hibi, I. H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R. Davis. JNK1: Cell 76:1025-1037 (1994).
19. H. K. Sluss, T. Barrett, B. Derijard, and R. J. Davis. Mol. Cell. Biol. 14:8376-8384 (1994).
20. Y. R. Chen, C. F. Meyer, and T. H. Tan. J. Biol. Chem. 271:631-634 (1996).
21. M. Karin. J. Biol. Chem. 270:16483-16486 (1995).
22. S. Gupta, D. Campbell, Derijard, and R. J. Davis. Science 267:389-393 (1995).
23. M. Cavigelli, F. Dolfi, F. X. Claret, and M. Karin. EMBO J. 14:5957-5964 (1995).
24. A.-N. T. Kong, P. Fei, and B. K. Wong. Pharm. Res. 12:309-312 (1995).
25. R. Yu, J. Jiao, J. Duh, T. Tan, and A.-N. T. Kong. Cancer Res. 56:2954-2959 (1996).
26. Z. G. Kathryn, Y. Liu, M. Gorospe, Q. Xu, and N. J. Holbrook. J. Biol. Chem. 271:4138-4142 (1996).
27. F. J. Staal, M. T. Anderson, G. E. J. Staal, L. A. Herzenberg, C. Gitler, and L. A. Herzenbeerg. Proc. Natl. Acad. Sci. USA 91:3619-3622 (1994).
28. P. Brennan and L. A. J. O'Neill. Biochim. Biophys. Acta. 1260:167-175 (1995).
29. K. P. Nephew, T. C. Polek, and S. A. Khan. Endocrinol. 137:219-224 (1996).